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Abstract 
Background: The effect of mitochondrial DNA variation on peripheral blood transcriptomics in 
health and disease is not fully known. Sex-specific mitochondrially controlled gene expression 
patterns have been shown in Drosophila melanogaster but in humans, evidence is lacking. Functional 
variation in mitochondrial DNA may also have a role in the development of type 2 diabetes and its 
precursor state, i.e. prediabetes. We examined the associations between mitochondrial SNPs 
(mtSNPs) and peripheral blood transcriptomics with a focus on sex- and prediabetes-specific effects. 
Methods: The genome-wide blood cell expression data of 19,637 probes, 199 deep-sequenced 
mtSNPs, and nine haplogroups of 955 individuals from a population-based Young Finns Study cohort 
were used. Significant associations were identified with linear regression and analysis of covariance. 
The effects of sex and prediabetes on the associations between gene expression and mtSNPs were 
studied using random-effect meta-analysis. 
Results: Our analysis identified 53 significant expression probe-mtSNP associations after Bonferroni 
correction, involving 7 genes and 31 mtSNPs. Eight probe-mtSNP signals remained independent after 
conditional analysis. In addition, five genes showed differential expression between haplogroups. The 
meta-analysis did not show any significant differences in linear model effect sizes between males and 
females but identified the association between the OASL gene and mtSNP C16294T to show 
prediabetes-specific effects. 
Conclusions: This study pinpoints new independent mtSNPs associated with peripheral blood 
transcriptomics and replicates six previously reported associations, providing further evidence of the 
mitochondrial genetic control of blood cell gene expression. In addition, we present evidence that 
prediabetes might lead to perturbations in mitochondrial control. 
4 
Introduction 
Mitochondrial DNA (mtDNA) is a maternally inherited, circular molecule containing approximately 
16,600 nucleotides which encode 22 transfer RNAs, 2 ribosomal RNAs and 13 polypeptides (1). It 
has a high mutation rate and these polymorphisms have accumulated during evolution, dividing the 
human population into smaller mitochondrial haplogroups. The definition of these haplogroups is 
based on particular combinations of certain single-nucleotide polymorphisms (SNPs) in mtDNA. 
Mitochondrial haplogroups are also associated with geographic areas and populations. For example, 
virtually all Scandinavian mtDNA falls into ten different haplogroups: H, I, J, K, M, T, U, V, W, and 
X. (2, 3) 
Mitochondrial DNA is transmitted mainly via the maternal lineage, which could create a male–
female asymmetry in the expected severity of mitochondrial disease (4). The mitochondrial SNPs 
(mtSNPs) that are deleterious to males but not to females, such as those that impair sperm function, 
will not be subject to natural selection. This may play an important role for male-specific effects in 
health and disease. (5) This hypothesis was tested in a study conducted with Drosophila 
melanogaster, which found sex-specific asymmetry in nuclear gene expression patterns. A strong 
effect of mtSNPs on nuclear gene expression was only observed in males; in females the 
mitochondrial effect was negligible (6). A non-sequencing–based study conducted on humans showed 
15 significant associations between mtSNPs and nuclear gene expression but found little evidence of 
a sex-specific mitochondrial control of gene expression (7). The number of studied mtSNPs was only 
78, and it is possible that the sex-specific effects are mediated via other mtSNPs not included in the 
study sample.⁠ 
Interaction among mtDNA and nuclear DNA encoded factors is important to cellular function 
and in adaptation to environmental changes. Since the co-evolution of these two genomes has been 
demonstrated at a protein-protein interaction level and some modes of co-regulation at a 
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transcriptional level also exist, it is logical that disruption in mitochondria-nuclear signaling may lead 
to disease. (8, 9)⁠ Some mtSNPs have been reported to be associated with type 2 diabetes (T2D), but 
this association has been seen only in Asians (10–12). A Korean study found mitochondrial 
haplogroups to be associated with an increased or decreased risk of T2D and with altered nuclear 
gene expression patterns that correlate with the susceptibility to develop T2D (13). However, it is 
unclear to what extent the mitochondrial-nuclear interaction is altered when the glucose homeostasis 
has already been impaired. Therefore, in addition to sex-specific differences, of special interest in this 
study is prediabetes, a precursor state and a major risk factor for the development of T2D (14). 
In this study, we wanted to a) replicate the earlier gene expression–mtSNP associations (7), b) to 
find new functional associations with a greater number of mtSNPs by using population-based mtDNA 
sequencing, c) to study the differential gene expression between the major Scandinavian haplogroups 
present in our study population, d) to investigate whether any gene expression–mtSNP associations 
show sex-specific differences, and, finally, e) to see whether gene expression–mtSNP associations are 
affected by the onset of prediabetes. 
Results 
Effect of mtSNPs and haplogroups on peripheral blood gene expression 
A total of 3,907,763 expression probe-mtSNP pairs were tested for association in a linear regression 
model. The genomic inflation factor was 1.00 (quantile-quantile plot for expected versus observed p-
values shown in Supplementary material, Figure S1), indicating that an inflation of the genetic 
association due to population stratification or undetected systematic error is unlikely. As shown in 
Table 1, a total of 53 expression probe-mtSNP pairs were significant after Bonferroni correction, 
corresponding to five nuclear and two mitochondrial genes and 31 mtSNPs. These seven identified 
genes regulated by mtSNPs were signal peptidase complex subunit 2 pseudogene 4 (SPCS2P4), ring 
finger protein 113A (RNF113A), signal peptidase complex subunit 2 (SPCS2), mitochondrially 
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encoded cytochrome c oxidase II (MT-CO2), cardiolipin synthase 1 (CRLS1), solute carrier family 25 
member 15 (SLC25A14), and mitochondrially encoded 16S RNA like 1 (MT-RNR2L1).  
The pairwise conditional analysis results for all significant mtSNPs with r2 > 0.30 are shown in 
online supplementary material, Table S1. As expected, the results were influenced by the extent of 
pairwise correlations and the strength of individual associations. Five probe-mtSNP pairs that 
survived all pairwise conditional analyses are shown in Table 2. The correlation was very low between 
the two mtSNPs that associated with MT-CO2 (r2 = 8.20 x 10-4) and only one mtSNP associated with 
MT-RNR2L1; these associations were not subjected to conditional analysis. In total, six mtSNPs 
(G8269A, G9055A, A11251G, C15452T, A16162G, and C16256T) had independent effect on gene 
expression. Figure 1 illustrates the normalized expression intensities for the top four genes relative to 
the alleles of the top associated independent mtSNP. 
ANCOVA and Tukey’s post hoc test indicated that five expression probes, corresponding to four 
nuclear and one mitochondrial genes, showed differential expression between haplogroups (λGC = 
1.04, Supplementary Figure S2). Three of the genes, SPCS2P4, RNF113A, and SLC25A14, were also 
associated with individual mtSNPs, but the other two genes, solute carrier family 2 member 8 
(SLC2A8, Illumina Array Address 5870326) and mitochondrially encoded NADH dehydrogenase 5 
(MT-ND5, Illumina Array Address 4880477), were not identified in the probe-mtSNP analysis. The 
results of Tukey’s post hoc test are shown in Table 3. Figure 2 illustrates the expression levels of the 
top two genes, SPCS2P4 and RNF113A, which were significantly lower in haplogroup K compared 
to all other eight major haplogroups. The expression levels of the other three genes across haplogroups 
are shown in Supplementary Figure S3. 
The genes identified to be associated with mtSNPs or haplogroups and not located in the 
mitochondrial genome were SPCS2P4, RNF113A, SPCS2, CRLS1, SLC25A14, and SLC2A8. None 
of these genes showed cross-hybridization with sequences on the mitochondrial genome. 
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Sex- and prediabetes-specific effects 
A random-effect meta-analysis showed no statistically significant differences in the effect sizes of 
gene expression between the sexes (results not shown). The characteristics of the population used in 
the prediabetes-specific analysis are shown in Table 4. Age, sex and body mass index all differed 
significantly between the groups (p ≤ 0.001).  For one probe-mtSNP pair the meta-analysis showed a 
significant difference in the effect sizes between subjects with prediabetes and controls. A p-value of 
8.91 x 10-9 (λGC = 0.99, Supplementary Figure S4) corresponded to the association between the 
expression of 2’-5’-oligoadenylate synthase like (OASL, Illumina Array Address ID 6280543) and 
mtSNP C16294T. Subjects with prediabetes had an effect estimate of -0.74 (standard error of 0.12) 
and a corresponding p-value of 9.69 x 10-6 (λGC = 0.99, Supplementary Figure S5), while the control 
group had an effect estimate of 0.43 (standard error of 0.12) and a p-value of 4.22 x 10-4   (λGC = 1.00, 
Supplementary Figure S6). When we added an interaction term between C16294T and prediabetes 
status to the linear model explaining the expression of OASL, the interaction between the minor allele 
T and the presence of prediabetes was significant (effect estimate -1.07, standard error 0.19, and a 
corresponding p-value of 1.11 x 10-8).  That is to say, on average, subjects with prediabetes and the 
minor allele T had lower expression levels of OASL compared to the reference allele, while subjects 
with the T allele but no prediabetes had higher expression levels compared to the reference allele, as 
can be seen in Figure 3. BLAST showed no evidence for cross-hybridization between OASL and 
sequences on the mitochondrial genome. 
Discussion 
In this study, we first wanted to replicate the earlier gene-mtSNP associations (7)⁠. We were able to 
replicate six of the 15 reported associations. The nucleotide sequence in these previous results differs 
from our sequence by one position; mtSNP A3481G in the previous sequence corresponds with 
A3480G in our sequence, and A10551G with A10550G. 
8 
Secondly, we set out to find new associations with a greater number of mtSNPs by using 
population-based mtDNA sequencing. From 3,907,763 analyzed expression probe-mtSNP pairs, we 
identified 47 new associations after a strict correction for multiple testing. The majority of the 
associations included either pseudogene SPCS2P4 in chromosome 1 or RNF113A in the X 
chromosome. The first is involved in the biosynthesis of the N-glycan precursor and transfer to a 
nascent protein, while the latter encodes a protein containing two zinc finger domains. 
After applying pairwise conditional analysis to all mtSNPs showing at least modest linkage 
disequilibrium, five probe-mtSNP pairs showed evidence for independent signaling. In the expression 
of SPCS2P4, the effects of G9055A and A11251G/C15452T were in opposite directions which also 
supports the independence of these signals. For SLC25A14 and CRLS1, none of the signals remained 
independent. This could be explained by the high linkage disequilibium (pairwise r2 > 0.89 for all 
mtSNPs), all variants that associated with these two genes in the unconditioned analysis together 
predispose to differential gene expression. In addition, the associations with mitochondrial genes MT-
CO2 and MT-RNR2L1 seem to result from independent signals. That is to say, in total, eight mtSNP-
gene associations were independent. 
We also discovered that the expression intensities of four nuclear and one mitochondrial genes 
differed between the major Scandinavian haplogroups present in our study population. The 
haplogroup distribution shown in Table 5 is similar to the one previously reported in Finnish 
population. Compared to other European populations, the frequency of haplogroup U appears to be 
higher and the frequency of haplogroup K lower in Finland. (3, 15) The lower intensities of SPCS2P4 
and RNF113A in haplogroup K result from the fact that the majority of the mtSNPs associated with 
these two genes (e.g. G9055A, A3480G, and A10550G) are also the defining variants for this 
haplogroup (16). The expression intensities of two genes, SLC2A8 and MT-ND5, were not associated 
at the mtSNP level. However, the majority of the mtSNPs (C295T, C462T, A12612G, G13708A, 
C16069T) defining haplogroup J (16)⁠ that associated with MT-ND5, were in the top 20 variants 
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associating with this gene. Those associations were not however significant after correction for 
multiple testing. For haplogroup U that associated with SLC2A8⁠, none of the defining variants were 
in top 20 mtSNPs associating with this gene. This implies that the haplogroup effect is driven by 
small individual effects of many mtSNPs, especially the expression of SLC2A8.⁠ 
As already discussed earlier (7), the biological relevance of these reported associations remain 
unclear, and they do not necessarily imply causal relationships—i.e. all these mtSNPs are not 
necessarily expression regulatory SNPs. However, the associations may equally represent the altered 
cellular activities resulting from the mtSNPs that the nuclear genome is then compensating for (13). 
In other studies, some of the reported mtSNPs have been associated with non-mitochondrial diseases. 
For example, the variant G9055A and haplogroup K have been found to increase breast cancer risk 
in European-American women (17). Interestingly, increased levels of protein coded by RNF113A in 
plasma have been suggested to act as a biomarker for breast cancer (18), while our analysis showed 
a reduced expression of RNF113A associated with this mtSNP and haplogroup. 
Our fourth aim was to investigate whether any probe–mtSNP associations show sex-specific 
differences by using a random-effect meta-analysis, which did not reveal any significant results. 
However, it is possible that sexually dimorphic effects on gene expression are mediated via other 
mtSNPs that were not included in this study. It is also worth mentioning that, to our knowledge, the 
only study that has previously examined these sex-specific effects in humans only took into account 
homoplasmic mtDNA alleles (7)⁠, which was also the case in the present study. For this reason, 
additional studies also considering heteroplasmic alleles are needed, although the link between 
heteroplasmy and sex-specific effects is not obvious. 
Finally, we tested the hypothesis that probe-mtSNP associations are affected by the onset of 
prediabetes. We were able to find support for this hypothesis by comparing the effect sizes between 
samples with and without prediabetes, which showed that the onset of prediabetes affects the 
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mitochondrial control of the expression of OASL through mtSNP C16294T. This mtSNP in the 
mtDNA control region has also been previously associated with cardiovascular risk factors, it has 
been linked to obesity in an Austrian population (19), and there is also evidence that C16294T is 
associated with coronary artery disease, although possibly through linkage to mtSNP T16189C (20).  
Functionally, OASL encodes an interferon-inducible antiviral protein, and its high expression levels 
in visceral adipose tissue, together with other three interferon signature genes, have been found to be 
positively correlated with adipose tissue and systemic insulin resistance (21). These previous results 
link OASL to prediabetes, since most persons with prediabetes are also insulin-resistant (22). Our 
results are in contrast to those published earlier in adipose tissue (21),⁠ since the expression of OASL 
was lower in T allele carriers with prediabetes compared those without prediabetes. However, 
profiling gene expression from peripheral blood leukocytes makes it challenging to speculate how 
the expression levels represent the expression in other tissues, such as adipose tissue.  One hypothesis 
based on our results would be that the chronic low-grade inflammation in prediabetes (23) is, to some 
extent, ⁠milder in individuals with mtSNP C16294T. Whether this has any clinical significance remains 
to be examined in longitudinal studies. In addition, the effect of prediabetes on probe-mtSNP 
associations should be replicated in other datasets. 
The prevalence of prediabetes in the non-diabetic Finnish population used in this study was 29.8 
%. In another Finnish cohort, the prevalence was 9.6 % in men and 10.4 % in women aged between 
45 and 54 years (24). The higher prevalence in our study can partly be explained by the lower cut-off 
point for impaired fasting glucose. In addition, the study sample used in (24)⁠ included also those with 
T2D, whereas they were excluded in the current study. The current prevalence is in line with the one 
reported in the United States, where 35 % of adults aged 20 years or older had prediabetes in 2005-
2008 (25). Although the prevalence is high, 5-10 % of individuals per year with prediabetes will 
progress to T2D, with the same proportion converting back to normoglycaemia (26)⁠.⁠ 
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The strength of this study is that the mtSNPs were obtained through deep sequencing. Compared 
to microarray genotyping, this increased the number of mtSNPs to be included in the analyses. This 
study also has some limitations. The Finnish gene pool has been shown to be distinctive, and the 
results may not be directly generalizable to populations with a different ethnic background, a fact that 
is pronounced in mitochondrial genetic studies. Another limitation is that no oral glucose tolerance 
tests were performed on the study population and the definition of prediabetes was based only on 
fasting plasma glucose and HbA1c levels. However, the HbA1c cut-off point for prediabetes has a 
high specificity to identify cases of impaired glucose tolerance (14). We also recognize that 
microarray studies are limited by multiple testing problems and false positives, although the number 
of false-positive results was minimized by using mitochondrial PCs as covariates and a strict 
Bonferroni correction. 
In summary, this study provides both novel and additional evidence for the mitochondrial genetic 
control of peripheral blood cell gene expression. No significant evidence of sex-specific effects of 
mtSNPs on gene expression were found, but we present evidence that the onset of prediabetes may 
lead to perturbations in this mitochondrial genetic control. The possible clinical relevance of these 
results remains to be examined in future functional and longitudinal studies. 
Materials and Methods 
Study participants 
The Cardiovascular Risk in Young Finns Study (YFS, http://youngfinnsstudy.utu.fi) is a Finnish 
longitudinal population study on the evolution of cardiovascular risk factors from childhood to 
adulthood (27). We used data from the follow-up in 2011 when the subjects were aged between 34 
and 49 years, with the exception of the mtDNA data, which was gathered in 2007. The follow-up 
studies in 2007 and 2011 included 2,204 and 2,060 participants, respectively. The study plan was 
approved by the ethics committees of all participating hospital districts, and the study protocol of 
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each study phase corresponded with the proposal by the World Health Organization. All subjects gave 
written informed consent, and the study was conducted in accordance with the Declaration of 
Helsinki. 
Blood transcriptomic analysis, RNA analysis, and data processing 
Whole-blood samples were obtained from 2,049 individuals for RNA isolation. 63 samples were 
discarded during the RNA isolation protocol, leading to 1,987 samples including one technical 
replicate taking part in the genome wide expression analysis. 322 samples had too low concentration 
after amplification step. After this, 1,667 samples (including three replicates, two from the mRNA 
amplification step) were analyzed with an Illumina HumanHT-12 version 4 Expression BeadChip 
(Illumina Inc.) containing 47,231 expression and 770 control probes. The transcripts detected 
(detection p-value < 0.01) in less than 5 % of samples were excluded from the analysis. After this 
filtering 19,637 genes were used for analysis. We disregarded four samples with less than 6,000 
significantly detected expression probes (detection p-value < 0.01). 
The expression data was processed in R (http://www.r-project.org/) using a nonparametric 
background correction, followed by quantile normalization with control and expression probes, using 
the neqc function in the limma package (28) and a log2 transformation. The expression levels were 
also zero-centered, and rank-based inverse normal transformation was applied to further normalize 
the expression levels. Based on RPS4Y1–2 and XIST mRNA levels on the Y and X chromosomes, 
respectively, we excluded nine samples due to mismatch with the recorded sex. After quality control, 
expression data were available for 1,654 samples including four technical replicates, which were used 
to examine batch effects and excluded subsequently. In summary, the expression analysis was 
successful for 19,637 probes and 1,650 samples. Other details of the process have been described 
previously by Turpeinen et al. (29). 
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Genomic DNA sample (n = 1,817) concentrations were measured from whole-blood samples with the 
Qubit BR dsDNA kit (Life Technologies Ltd). Mitochondrial DNA was amplified from the genomic 
DNA using the REPLI-g Mitochondrial DNA kit (Qiagen) in a 15 µl reaction volume. After the 
enrichment, the amplified mtDNA samples were processed into Illumina deep sequencing compatible 
libraries with the Nextera DNA sample preparation kit (Illumina Inc.). The mtDNA concentrations 
were measured with Qubit dsDNA for Nextera tagmentation reaction. The reaction volume in the 
Nextera tagmentation and amplification steps was 20 µl, and after both steps the libraries were 
purified with a EdgeBio Performa V3 96-Well Short Plate (Edge BioSystems). After the 
amplification, the libraries were first incubated with 4 µl of EdgeBio SOPE Resin and then purified 
with EdgeBio Performa plates. After purification, 48 samples with different index tags were pooled 
together (2 µl each) in each pool and concentrated with DNA Clean & ConcentratorTM-5 (Zymo 
Research). The final volume of the concentrated pool was 15 µl. The sequencing-ready libraries were 
quantitated with an Agilent 2100 Bioanalyzer High Sensitivity kit (Agilent). The libraries were deep-
sequenced with the Illumina HiSeq system. All the samples (n = 1,667) that achieved any mean bait 
coverage were included in the quality control process. 
The primer sites in the REPLI-g kit have not been published and the data for each of the 16 
samples was therefore validated by amplifying the mtDNA in two different PCR amplicons covering 
the whole mtDNA. The primers have been previously described by Pietiläinen et al. (30). The 
amplicons were processed into Illumina-compatible sequencing libraries according to the same 
Nextera protocol as detailed above. The data was analyzed using an in-house-developed 
bioinformatics pipeline (31). The variants from REPLI-g amplification and PCR amplification were 
compared, and no significant differences were observed. The comparison results confirm that REPLI-
g primers do not affect the variant detection. 
MtDNA sequencing
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First, samples with individual missingness > 0.10 (134 samples) were excluded. Next, samples were 
classified into haplogroups by using HaploGrep (32) (Phylotree build 16) (16) after comparison to 
the revised Cambridge Reference Sequence (rCRS) (1). Only those individuals whose haplogroup 
quality score was above 0.90 were included for further analyses (66 samples rejected). At this quality 
threshold, haplogroup assignment is quite reliable, according to the HaploGrep manual. After this, 
1,467 samples remained for further analysis. Then, samples that had both gene expression and 
mtDNA data were merged, after which 955 samples were remaining. Next, 29 mtSNPs that obtained 
mean call rates of < 0.85 were excluded, all samples had mean call rate above this value. After this, 
heteroplasmic alleles’ status were set to missing. The remaining quality control steps included 
filtering for missingness by mtSNP > 0.05 (34 mtSNPs discarded), and minor allele frequency (MAF) 
< 0.01 (538 mtSNPs discarded). After these procedures, a total of 199 mtSNPs from 955 samples 
(548 women and 407 men) were available for probe-mtSNP association analysis (Supplementary 
Material, Table S2). 
 For association testing, the haplogroups were assigned to major haplogroups. Haplogroups with 
a frequency of less than 0.01 were excluded, leaving 934 samples for the haplogroup-probe analysis. 
The haplogroup frequencies are shown in Table 5. All major Scandinavian haplogroups except 
haplogroup M were present (3)⁠. 
Definition of prediabetes 
Venous blood samples were drawn after an overnight fast for the determination of serum glucose and 
glycated hemoglobin A1c (HbA1c). The classification of prediabetes was based on fasting glucose 
and HbA1c according to the criteria of the American Diabetes Association (14). People with impaired 
fasting glucose were defined as having a fasting plasma glucose level of 5.6–6.9 mmol/L or an HbA1c 
level of 39–47 mmol/mol without a diagnosis of T2D. The diagnosis of T2D included subjects with 
a fasting plasma glucose level of 7.0 mmol/L or higher or an HbA1c level of 48 mmol/mol or higher, 
MtDNA quality control and data processing 
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or those who reported using oral glucose‐lowering medication or insulin (but had not reported having 
type 1 diabetes), or who had a reported diagnosis of T2D by a physician. Those diagnosed with type 
1 diabetes were also ruled out. Of the 833 subjects for whom gene expression and mtDNA data and 
prediabetes status were available, 249 had prediabetes, and 584 controls had normal levels of fasting 
plasma glucose and HbA1c. 
Statistical analysis 
In order to investigate the association of peripheral blood gene expression with mtSNPs, the 
expression levels were modeled as a linear function of the presence (coded as 1) or absence (coded 
as 0) of the minor allele using the lm function in R. Age and sex were added as covariates to the linear 
model. We calculated the p-values using a standard F test with one degree of freedom and accounted 
for multiple testing using the Bonferroni correction. Significance was defined as p < 1.28 × 10-8 (i.e. 
0.05/[199 × 19,637]). With this p-value, MAF of 0.01, and a minimum statistical power of 0.80, the 
minimum detectable effect size was 1.58. With MAF of 0.05, the minimum effect size was 0.72. (33)⁠ 
Analysis of covariance (ANCOVA) with age and sex as covariates was employed to flag genes for 
those showing differential expression between haplogroups. All genes with a p-value of < 2.55 × 10-
6 (i.e. 0.05/19,637) were compared using Tukey’s honest significant difference test to confirm the 
between-haplogroup differences. A Tukey-adjusted p-value of < 0.05 was considered statistically 
significant. 
The sex-specific effects of mtSNPs on gene expression were tested by applying the same linear 
model as described above (sex was removed from the covariates) to males and females separately. 
Differences in effect sizes were compared by applying a random-effect meta-analytic model to each 
probe using the MetaDE package (34). Heterogeneity was examined by Cochran’s Q test with the 
corresponding p-value. A significant p-value would suggest that there is a significant difference in 
effect sizes between the sexes. For the sex-specific meta-analysis, the number of mtSNPs tested was 
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156 because for some mtSNPs the minor allele frequency was less than 0.01 in either males or females 
(Supplementary Material, Table S3). Significance was then defined as p < 1.63 × 10-8 (i.e. 0.05/[156 
× 19,637]). 
The effect of prediabetes on the association between mtSNPs and gene expression was studied 
similarly. Age, sex, and body mass index were added as covariates to the linear regression models. 
The number of mtSNPs included was now 127, resulting in significance in random-effect meta-
analysis defined as p < 2.00 × 10-8 (i.e. 0.05/[127 × 19,637]) (Supplementary Material, Table S4). The 
Mann-Whitney U test was used for age and body mass index and the χ2 test for sex when the two 
groups were compared. After identifying the significant associations, we also studied the interaction 
between significant mtSNPs and prediabetes status on the expression of pinpointed genes by adding 
an interaction term to the linear model described above. 
Principal component (PC) analysis was performed on all nuclear probes passing quality control. 
The prcomp function (package stats) was used to calculate nuclear PCs 1–20 from mean expression 
levels. The use of gene expression principal components should reduce the effect of technical factors 
(Illumina chip assignment, the RNA amplification batch, the RNA isolation batch, and the sample 
storage time, in particular the time between blood donation and RNA isolation) in our data (35)⁠. The 
use of mitochondrial PCs has been demonstrated to be a robust method to control of confounding due 
to population stratification. In addition, the use of mitochondrial PCs effectively removes false-
positive associations but does not cause loss in power for detection of true associations. (36) PC 
analysis was performed on all mtSNPs passing quality control. Since the mtSNP were represented as 
binary variables, i.e. the presence or absence of minor allele, logisticPCA package (37) was used to 
extract mitochondrial PCs 1-20. 
Both nuclear and mitochondrial PCs were added as covariates, in addition to those mentioned 
above, in the linear mtSNP association models until no additional reduction in genomic inflation 
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factor (λGC) could be achieved. Nuclear PCs 1–11 and mitochondrial PCs 1–2 were used for all probe-
mtSNP association analyses. For haplogroup analysis in ANCOVA, nuclear PCs 1–11 were used. 
Mitochondrial PCs cannot be applied to haplogroup analysis, since the haplogroups are strongly 
correlated with the mitochondrial PCs. The genomic inflation factor was calculated using the 
GenABEL package (38). Values of λGC < 1.05 are generally considered benign (39). 
For all significant mtSNPs for each probe, pairwise linkage disequilibrium between mtSNPs was 
quantified as squared Pearson correlation r2. All significant mtSNPs in at least modest pairwise 
linkage disequilibrium (r2 > 0.30) were subjected to pairwise conditional analysis in order to identify 
the independent signals. Conditional analysis was performed by using the same linear model as in the 
full analysis but additionally conditioning for one additional significant mtSNP at a time. We applied 
a mtSNP-specific Bonferroni correction (i.e., correction for the number of pairwise analyses made 
for each mtSNP) to account for multiple testing. 
All significant probes from the above analyses were tested for cross-hybridization with 
sequences other than the target transcript using algorithm blastn from BLAST (40). We were 
particularly interested in probes that have sequence similarities with the mtDNA. Probes were 
considered to show strong evidence for cross-hybridization with the mtDNA if probes’ sequences had 
90 % identity over the aligned region, at least 40 of 50 matching bps, and no gaps. 
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Figure 1. Combined boxplot and violin plot of the normalized expression intensities for the top four 
genes relative to the alleles of the top associated independent mtSNP. 
26 
Figure 2. Combined boxplot and violin plot of the normalized expression intensities of SPCS2P4 
and RNF113A across the haplogroups. 
27 
Figure 3.  Combined boxplot and violin plot of the normalized expression intensities of OASL 
across the individuals with and without prediabetes relative to mtSNP C16294T. 
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Table 1. 53 probe-mtSNP associations that had a p of < 1.28×10-8. The beta-coefficient represents 
the proportion of 1 SD change in normalized gene expression intensity (mean = 0, SD = 1).  An 
asterisk (*) marks the associations that were replicated from the previous results (7)⁠⁠.
Gene Illumina array ID mtSNP MAF Beta SE P-value Replication 
SPCS2P4 4210315 G9055A 0.04 -1.11 0.08 1.81 x 10-39 
SPCS2P4 4210315 A3480G 0.04 -1.09 0.09 4.84 x 10-32 * 
SPCS2P4 4210315 A10550G 0.04 -1.08 0.09 9.49 x 10-32 * 
SPCS2P4 4210315 C14167T 0.04 -1.08 0.09 9.49 x 10-32 
SPCS2P4 4210315 T16224C 0.05 -0.95 0.08 1.77 x 10-30 
SPCS2P4 4210315 T11299C 0.04 -1.03 0.09 5.94 x 10-29 
SPCS2P4 4210315 T1189C 0.03 -1.04 0.09 1.17 x 10-27 
RNF113A 6940196 G9055A 0.04 -1.23 0.13 2.48 x 10-21 
SPCS2P4 4210315 T9698C 0.05 -0.74 0.08 1.01 x 10-19 * 
RNF113A 6940196 C14167T 0.04 -1.25 0.14 1.87 x 10-18 
RNF113A 6940196 A10550G 0.04 -1.24 0.14 1.95 x 10-18 
RNF113A 6940196 A3480G 0.04 -1.24 0.14 2.70 x 10-18 
SPCS2P4 4210315 A9093G 0.02 -1.03 0.12 4.72 x 10-18 
RNF113A 6940196 T11299C 0.04 -1.20 0.14 1.21 x 10-17 
RNF113A 6940196 T1189C 0.03 -1.23 0.14 4.42 x 10-17 
SPCS2P4 4210315 T9903C 0.02 -1.06 0.12 7.24 x 10-17 
SPCS2P4 4210315 T14798C 0.10 -0.60 0.07 9.74 x 10-16 
SPCS2P4 4210315 A1811G 0.08 -0.50 0.07 4.86 x 10-14 
RNF113A 6940196 T16224C 0.05 -0.96 0.13 8.58 x 10-14 
SPCS2 7040068 G9055A 0.04 -0.93 0.12 9.59 x 10-14 
CRLS1 2710446 A8869G 0.02 -0.75 0.10 5.30 x 10-13 
CRLS1 2710446 T4639C 0.02 -0.75 0.10 8.45 x 10-13 
SPCS2P4 4210315 G11377A 0.03 -0.76 0.11 2.19 x 10-12 
RNF113A 6940196 T9698C 0.05 -0.87 0.12 2.57 x 10-12 
CRLS1 2710446 C5263T 0.02 -0.75 0.11 5.28 x 10-12 
RNF113A 6940196 A9093G 0.02 -1.23 0.18 7.40 x 10-12 
MT-CO2 6550386 G8269A 0.01 -1.62 0.24 2.09 x 10-11 * 
SPCS2P4 4210315 A11251G 0.12 1.04 0.15 2.64 x 10-11 
SPCS2P4 4210315 C15452A 0.12 1.03 0.15 5.58 x 10-11 
RNF113A 6940196 T9903C 0.02 -1.24 0.19 2.04 x 10-10 
SLC25A14 1710754 A3505G 0.05 0.77 0.12 3.28 x 10-10 
SLC25A14 1710754 T1243C 0.05 0.76 0.12 4.54 x 10-10 
RNF113A 6940196 T14798C 0.10 -0.72 0.11 4.76 x 10-10 
SPCS2 7040068 A3480G 0.04 -0.85 0.14 4.81 x 10-10 * 
SPCS2 7040068 A10550G 0.04 -0.85 0.14 5.04 x 10-10 * 
MT-RNR2L1 1230164 C16256T 0.07 0.39 0.06 5.28 x 10-10 
SPCS2 7040068 C14167T 0.04 -0.85 0.14 5.44 x 10-10 
SPCS2 7040068 T16224C 0.05 -0.76 0.12 9.72 x 10-10 
SLC25A14 1710754 A11947G 0.05 0.75 0.12 1.03 x 10-9 
SLC25A14 1710754 G8994A 0.05 0.74 0.12 1.09 x 10-9 
RNF113A 6940196 T4216C 0.12 1.32 0.22 1.44 x 10-9 
29 
SLC25A14 1710754 G5046A 0.05 0.74 0.12 1.76 x 10-9 
SPCS2P4 4210315 A10398G 0.14 -0.40 0.07 1.80 x 10-9 
SLC25A14 1710754 G15884C 0.05 0.74 0.12 2.25 x 10-9 
RNF113A 6940196 A1811G 0.08 -0.60 0.10 3.43 x 10-9 
RNF113A 6940196 C15452A 0.12 1.39 0.24 5.22 x 10-9 
MT-CO2 6550386 A16162G 0.06 -0.66 0.11 5.48 x 10-9 
SPCS2 7040068 T11299C 0.04 -0.79 0.13 7.40 x 10-9 
RNF113A 6940196 A11251G 0.12 1.36 0.23 7.84 x 10-9 
SLC25A14 1710754 T12414C 0.05 0.69 0.12 8.01 x 10-9 
SPCS2 7040068 T1189C 0.03 -0.82 0.14 8.27 x 10-9 
SLC25A14 1710754 G5460A 0.05 0.65 0.11 9.93 x 10-9 
RNF113A 6940196 G11377A 0.03 -0.93 0.16 1.18 x 10-8 
Abbreviations: MAF, minor allele frequency; SE, standard error; SD, standard deviance 
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Table 2. Independent mtSNP-gene association signals from the pairwise conditional analysis. The 
beta-coefficient represents the proportion of 1 SD change in normalized gene expression intensity 
(mean = 0, SD = 1). The mtSNP-specific Bonferroni-corrected p-value accounts for the number of 
pairwise analyses made for each mtSNP and is defined as the limit of significance. 
Gene mtSNP Conditional 
p-value 
Conditional beta Conditional SE mtSNP-specific Bonferroni-
corrected p-value 
SPCS2P4 G9055A 1.80 x 10-9 –  4.14 x 10-29 -0.97 – -1.36 0.09 – 0.20 4.17 x 10-3 
SPCS2P4 A11251G 1.41 x 10-3 0.97 0.30 5.00 x 10-2 
SPCS2P4 C15452A 4.28 x 10-6 1.13 0.24 5.00 x 10-2 
RNF113A G9055A 1.40 x 10-4 – 2.82 x 10-14 -1.18 – -1.36 0.14 – 0.32 4.17 x 10-3 
SPCS2 G9055A 3.68 x 10-5 – 1.38 x 10-6 -0.90 – -1.39 0.21 – 0.31 8.33 x 10-3 
Abbreviations: SE, standard error; SD, standard deviance 
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Table 3. Haplogroup-wise comparisons from Tukey’s post-hoc test for the five differentially 
expressed genes identified in ANCOVA. One unit of difference in means represents the proportion 
of 1 SD change in normalized gene expression intensity.
Comparison Difference in means [95% CI] Tukey-adjusted p-value 
SPCS2P4 
K-H -1.27 [-1.80, -0.73] 1.33 x 10-11 
K-U -1.23 [-1.78, -0.68] 2.38 x 10-10 
K-J -1.30 [-1.93, -0.67] 8.57 x 10-9 
K-W -1.35 [-2.04, -0.66] 6.08 x 10-8 
K-V -1.17 [-1.82, -0.52] 9.93 x 10-7 
K-T -1.10 [-1.78, -0.43] 1.55 x 10-5 
K-I -1.47 [-2.38, -0.55] 2.74 x 10-5 
K-X -1.28 [-2.14, -0.43] 1.09 x 10-4 
RNF113A 
K-H -1.44 [-1.97, -0.91] 
K-U -1.53 [-2.07, -0.99] 
K-J -1.52 [-2.14, -0.90] 2.48 x 10-12 
K-T -1.44 [-2.10, -0.77] 1.06 x 10-9 
K-W -1.42 [-2.10, -0.74] 4.73 x 10-9 
K-X -1.48 [-2.32, -0.65] 1.65 x 10-6 
K-I -1.57 [-2.47, -0.67] 2.75 x 10-6 
K-V -1.03 [-1.67, -0.39] 2.21 x 10-5 
K-U -0.50 [-0.94, -0.06] 1.20 x 10-2 
SLC25A14 
W-J 0.81 [0.21, 1.41] 1.01 x 10-3 
W-H 0.55 [0.06, 1.05] 1.63 x 10-2 
K-J 0.69 [0.05, 1.33] 2.53 x 10-2 
W-X 0.86 [0.02, 1.69] 3.79 x 10-2 
SLC2A8 
U-J -0.46 [-0.88, -0.04] 2.06 x 10-2 
U-H -0.25 [-0.50, 0.00] 4.34 x 10-2 
MT-ND5 
J-V 0.84 [0.30, 1.39] 7.05 x 10-5 
J-U 0.59 [0.16, 1.01] 5.78 x 10-4 
J-H 0.50 [0.10, 0.91] 3.24 x 10-3 
J-W 0.69 [-1.29, -0.09] 1.14 x 10-2 
Abbreviations: CI, confidence interval; SD, standard deviance 
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Table 4. Characteristics of the population used in the prediabetes-specific analysis. Values are 
means (SD). The Mann-Whitney U test was used for age and body mass index and the χ2 test for 
sex when the two groups were compared. P-value ≤ 0.001 for all comparisons. 
Controls Individuals with prediabtes 
Number of subjects in group 584 249 
Age, years 41.6 (5.00) 42.8 (5.10) 
Males (%) 202 (34.5) 143 (57.4) 
Body mass index, kg/m2 25.5 (4.16) 28.6 (5.42) 
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Table 5. Absolute and relative mitochondrial haplogroup frequencies in the study population. 
Haplogroup Absolute frequency Relative frequency (%) 
H 405 43.4 
U 240 25.7 
J 69 7.4 
V 58 6.2 
T 48 5.1 
W 43 4.6 
K 35 3.7 
X 20 2.1 
I 16 1.7 
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Abbreviations 
mtDNA, mitochondrial DNA; mtSNP, mitochondrial single nucleotide polymorphism; T2D, type 2 
diabetes; YFS, Young Finns Study; MAF, minor allele frequency; HbA1c, glycated hemoglobin; 
ANCOVA, analysis of covariance; PC principal component; SE, standard error; SD, standard 
deviance; CI, confidence interval  
